Jean Yves Bonnefoys

Biography

Jean-Yves Bonnefoy is the CEO of Anagenesis Biotechnologies. In his previous positions, he was the CEO and the founder of Elsalys, a startup dedicated to the development of first-in-class antibodies for cancer therapies and he previously was the Vice President, Research and Development of Transgene in charge of Research, Clinical Development, Regulatory Affairs and Intellectual Property. Prior to joining Transgene, he was Head of the Canceropôle Lyon Rhônes-Alpes. From 1997 to 2002, he was Director of the Immunology Center of the Pierre Fabre Group in Saint-Julien en Genevois, France. He previously was responsible for the Immunology Department of the Biomedical Research Institute of the Glaxo-Wellcome Group in Geneva, Switzerland. Jean-Yves Bonnefoy holds a PhD in immunology from the Lyon University and has completed the Senior Management Program of the London Business School.

Research Interest

Biotechnology